Isoniazid-Resistant Rifampicin-Susceptible Tuberculosis in Children

被引：1
|
作者：
Morales Perez, Celia [1 ]
Gomez-Pastrana, David [1 ]
Aragn Fernandez, Carmen [1 ]
Perez Escolano, Elvira [2 ]
机构：
[1] Hosp Materno Infantil Jerez, Serv Pediat, Unidad Neumol Infantil, Cadiz, Spain
[2] Hosp Jerez, Serv Med Interna, Cadiz, Spain
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2019年 / 55卷 / 07期
关键词：
D O I：
10.1016/j.arbres.2018.10.014
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：388 / 390
页数：3
相关论文
共 50 条
  • [21] Isoniazid-resistant tuberculosis: a cause for concern?
    Stagg, H. R.
    Lipman, M. C.
    McHugh, T. D.
    Jenkins, H. E.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (02) : 129 - 139
  • [22] FATE OF PATIENT WITH ISONIAZID-RESISTANT TUBERCULOSIS
    RUCHELMA.HH
    CHOFNAS, I
    JOURNAL OF CHRONIC DISEASES, 1962, 15 (OCT): : 965 - &
  • [23] Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
    Jhun, Byung Woo
    Koh, Won-Jung
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2020, 83 (01) : 20 - 30
  • [24] Molecular Characterization of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Strains Isolated in Kazakhstan
    Kozhamkulov, Ulan
    Akhmetova, Ainur
    Rakhimova, Saule
    Belova, Elena
    Alenova, Arike
    Bismilda, Venera
    Chingissova, Lyailya
    Ismailov, Shahimurat
    Ramanculov, Erlan
    Momynaliev, Kuvat
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2011, 64 (03) : 253 - 255
  • [25] Clinical Relevance of Rifampicin-Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis Patients
    Vogensen, Vanessa B.
    Bolhuis, Mathieu S.
    Sturkenboom, Marieke G. G.
    van der Werf, Tjip S.
    de Lange, Wiel C. M.
    Anthony, Richard M.
    van Soolingen, Dick
    Alffenaar, Jan-Willem
    Kerstjens, Huib A. M.
    Akkerman, Onno W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [26] Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children
    H. S. Schaaf
    T. C. Victor
    E. Engelke
    W. Brittle
    B. J. Marais
    A. C. Hesseling
    P. D. van Helden
    P. R. Donald
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 203 - 205
  • [27] SILA-421 activity in vitro against rifampicin-susceptible and rifampicin-resistant Mycobacterium tuberculosis, and in vivo in a murine tuberculosis model
    de Knegt, Gerjo J.
    Bakker-Woudenberg, Irma A. J. M.
    van Soolingen, Dick
    Aarnoutse, Rob
    Boeree, Martin J.
    de Steenwinkel, Jurriaan E. M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (01) : 66 - 72
  • [28] Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children
    Schaaf, H. S.
    Victor, T. C.
    Engelke, E.
    Brittle, W.
    Marais, B. J.
    Hesseling, A. C.
    van Helden, P. D.
    Donald, P. R.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (03) : 203 - 205
  • [29] FAILURE OF ISONIAZID PROPHYLAXIS AFTER EXPOSURE TO ISONIAZID-RESISTANT TUBERCULOSIS
    FAIRSHTER, RD
    RANDAZZO, GP
    GARLIN, J
    WILSON, AF
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1975, 112 (01): : 37 - 42
  • [30] Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis
    Hofmann-Thiel, S.
    Molodtsov, N.
    Duffner, C.
    Kadyrov, A.
    Kalmambetova, G.
    Kabirov, O.
    Rajabov, A.
    Parpieva, N.
    Sayfutdinov, Z.
    Vogel, M.
    Vogel, H.
    Antonenka, U.
    Hoffmann, H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2019, 23 (04) : 458 - 464
12345